EUVIMEDEUVIMED entdecken
Übersichtsarbeit

CYP1A inhibitors: Recent progress, current challenges, and future perspectives

Ziru Dai, Yue Wu, Yuan Xiong, Jingjing Wu, Min Wang, Xiao Sun, Xinxin Ding, Ling Yang, Xiaobo Sun, Guangbo Ge

Medicinal Research Reviews · 2024

DOI: 10.1002/med.21982 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, 2024. Verfasst von Ziru Dai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Deve…. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP1A1, Cytochrome P-450 CYP1A2. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 254 Literaturangaben. Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences, Shanghai Science and Technology Innovation Action Plans.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mammalian cytochrome P450 1A (CYP1A) are key phase I xenobiotic‐metabolizing enzymes that play a distinctive role in metabolic activation or metabolic clearance of a variety of procarcinogens, drugs, and endogenous substances. Human CYP1A subfamily contains two members (hCYP1A1 and hCYP1A2), which are known to catalyze the oxidative activation of some environmental procarcinogens into carcinogenic species. Increasing evidence has demonstrated that CYP1A inhibitor therapies are promising strategies for cancer chemoprevention or overcoming CYP1A‐associated drug toxicity and resistance. Herein, we reviewed recent advances in the discovery and characterization of hCYP1A inhibitors, from the discovery approaches to structural features and biomedical applications of hCYP1A inhibitors. The inhibition potentials, inhibition modes, and inhibition constants of all reported hCYP1A inhibitors are comprehensively summarized. Meanwhile, the structural features and structure–activity relationships of different classes of hCYP1A1 and hCYP1A2 inhibitors are analyzed and discussed in depth. Furthermore, the major challenges and future directions for this field are presented and highlighted. Collectively, the information and knowledge presented here will strongly facilitate the researchers to discover and develop more efficacious CYP1A inhibitors for specific purposes, such as chemo‐preventive agents or as tool molecules in hCYP1A–related fundamental studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP1A1Cytochrome P-450 CYP1A2AnimalsHumansCytochrome P-450 Enzyme SystemMammals

Stichwörter der Autor:innen

CYP1A1CYP1A2cytochrome P450inhibitorsstructure-activity relationships (SARs)

Substanzen

Cytochrome P-450 CYP1A1Cytochrome P-450 CYP1A2Cytochrome P-450 Enzyme System

Autor:innen und Institutionen

  • Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical Co…
  • Shanghai Frontiers Science Center for TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China.
  • Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, America.
  • Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, China.

Förderung

  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences
  • Shanghai Science and Technology Innovation Action Plans
  • Shanghai Municipal Health Commission's TCM research project
  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine

Zitieren

APA

Dai, Z., Wu, Y., Xiong, Y., Wu, J., Wang, M., Sun, X., Ding, X., Yang, L., Sun, X., & Ge, G. (2024). CYP1A inhibitors: Recent progress, current challenges, and future perspectives. Medicinal Research Reviews. https://doi.org/10.1002/med.21982

Vancouver

Dai Z, Wu Y, Xiong Y, Wu J, Wang M, Sun X, et al. CYP1A inhibitors: Recent progress, current challenges, and future perspectives. Medicinal Research Reviews. 2024. doi:10.1002/med.21982

BibTeX
@article{Dai2024,
  author = {Dai, Ziru and Wu, Yue and Xiong, Yuan and Wu, Jingjing and Wang, Min and Sun, Xiao and Ding, Xinxin and Yang, Ling and Sun, Xiaobo and Ge, Guangbo},
  title = {CYP1A inhibitors: Recent progress, current challenges, and future perspectives},
  journal = {Medicinal Research Reviews},
  year = {2024},
  doi = {10.1002/med.21982}
}
Kostenlos starten →